Chemours Buy Hold or Sell Recommendation

CC -- USA Stock  

USD 16.62  0.46  2.69%

Allowing for the 30-days total investment horizon, and your above average risk tolerance our recommendation regarding Chemours Company is 'Sell'. Macroaxis provides Chemours buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Chemours positions. The advice algorithm takes into account all of Chemours available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Chemours buy-and-hold prospective. Check also Chemours Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell ChemoursBuy Chemours
Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
For the selected time horizon Chemours Company has a mean deviation of 3.2, semi deviation of 0.0, standard deviation of 4.4, variance of 19.4, downside variance of 0.0 and semi variance of 0.0
Our buy or sell advice tool can be used to cross verify current analyst consensus on Chemours and to analyze the company potential to grow in the current economic cycle. To make sure Chemours is not overpriced, please confirm all Chemours fundamentals including its Shares Owned by Institutions, Price to Sales and the relationship between Shares Outstanding and Price to Earning . Given that Chemours has Number of Shares Shorted of 11.3M, we suggest you validate Chemours Company market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Chemours Trading Alerts and Improvement Suggestions

Chemours generates negative expected return over the last 30 days
Chemours has high historical volatility and very poor performance
Chemours has high likelihood to experience some financial distress in the next 2 years
Chemours has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its debt commitments
CIRCUIT CITY STRS reports about 630M in cash with (108.38M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.85.
Over 83.0% of the company shares are held by institutions such as insurance companies
Latest headline from uspostnews.com: This Signal Can Foreshadow A Significant Move In Camber Energy , The Chemours Company - US Post News

Chemours current analysts recommendations

Target Median Price18.00
Target Mean Price22.46
Recommendation Mean2.50
Target High Price43.00
Number Of Analyst Opinions13
Target Low Price13.00

Chemours Returns Distribution Density

Mean Return0.38Value At Risk6.21
Potential Upside6.62Standard Deviation4.40
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Fmr LlcCommon Shares23.6 M566.9 M
Blackrock IncCommon Shares16.1 M386.7 M
Vanguard Group IncCommon Shares15.5 M372 M
State Street CorpCommon Shares5.7 M136.1 M
Third Point LlcCommon Shares4.4 M105 M
Lsv Asset ManagementCommon Shares3.9 M92.7 M
Greenlight Capital IncCommon Shares3.7 M89.3 M
Sandler Capital ManagementPut Options2 M48 M
Point72 Asset Management LpCall Options1.2 M30 M

Chemours Greeks

α
Alpha over DOW
=0.4
β
Beta against DOW=0.32
σ
Overall volatility
=4.48
Ir
Information ratio =0.1

Chemours Volatility Alert

Chemours Company exhibits very low volatility with skewness of -1.04 and kurtosis of 3.91. However, we advise investors to further study Chemours Company technical indicators to make sure all market info is available and is reliable.
    
 Better Than Average     
    
 Worse Than Average Compare Chemours to competition

Chemours Fundamental Vs Peers

FundamentalsChemoursPeer Average
Return On Equity65.37% (0.31)%
Return On Asset6.63% (0.14)%
Profit Margin10.31% (1.27)%
Operating Margin18.36% (5.51)%
Current Valuation6.6B16.62B
Shares Outstanding163.48M571.82M
Shares Owned by Insiders0.66% 10.09%
Shares Owned by Institutions82.83% 39.21%
Number of Shares Shorted11.3M4.71M
Price to Earning4.91X28.72X
Price to Book3.39X9.51X
Price to Sales0.48X11.42X
Revenue5.88B9.43B
Gross Profit1.97B27.38B
EBITDA1.08B3.9B
Net Income606M570.98M
Cash and Equivalents630M2.7B
Cash per Share3.85X5.01X
Total Debt4.55B5.32B
Debt to Equity548.40% 48.70%
Current Ratio1.96X2.16X
Book Value Per Share5.03X1.93K
Cash Flow from Operations(108.38M)971.22M
Short Ratio2.94X4.00X
Earnings Per Share3.48X3.12X
Price to Earnings To Growth4.19X4.89X
Number of Employees7K18.84K
Beta2.33-0.15
Market Capitalization2.79B19.03B
Total Asset6.3B29.47B
Retained Earnings193.24M9.33B
Working Capital835M1.48B
Current Asset2.3B9.34B
   Acquisition by David Shelton of 19908 shares of Chemours subject to Rule 16b-3 [view details]
Search macroaxis.com